VELPHORO

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug VELPHORO contains one active pharmaceutical ingredient (API):

1 Sucroferric oxyhydroxide UNII 87PZU03K0K - FERRIC OXYHYDROXIDE

Sucroferric oxyhydroxide is also known as a mixture of polynuclear iron(III)-oxyhydroxide (pn-FeOOH), sucrose and starches. Phosphate binding takes place by ligand exchange between hydroxyl groups and/or water and the phosphate ions throughout the physiological pH range of the gastrointestinal tract. Serum phosphorus levels are reduced as a consequence of the reduced dietary phosphate absorption. Read about Sucroferric oxyhydroxide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VELPHORO Chewable tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE05		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10230K, 10233N, 10250L
Country: CA	Health Products and Food Branch	Identifier(s): 02471574
Country: EE	Ravimiamet	Identifier(s): 1663264, 1663275, 1833432
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114943002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 587946
Country: FR	Base de données publique des médicaments	Identifier(s): 62955775
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 283924
Country: HK	Department of Health Drug Office	Identifier(s): 66585
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7843
Country: IT	Agenzia del Farmaco	Identifier(s): 043564018, 043564020, 043564032, 043564044, 043564057
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1074207, 1074208, 1074209, 1074210, 1091491
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 129496
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100326520
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67500001, W67500002
Country: SG	Health Sciences Authority	Identifier(s): 14727P
Country: US	FDA, National Drug Code	Identifier(s): 49230-645